Identification and Prospective Replication of an EEG Biomarker for Predicting the Antidepressant Effect of ALTO300 in Patients With Major Depression: Results From a Large Phase 2a Study
NEUROPSYCHOPHARMACOLOGY（2023）
Key words
Precision Psychiatry,Major Depressive Disorder,(MDD),Depression Subtypes,EEG Biomarkers,Phase II Clinical Trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined